Skip to content

Drug interactions

Letermovir + Ondansetron

Severity: Minor

Letermovir and Ondansetron: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir is a moderate CYP3A inhibitor and may modestly increase ondansetron levels. Since ondansetron has multiple clearance pathways, the effect is generally small.

What this interaction means in plain words

Letermovir and Ondansetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Letermovir belongs to Anti Virals; Ondansetron belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 by letermovir reduces one pathway of ondansetron metabolism.

What to do

No empirical dose adjustment is needed. Monitor for QT-related effects in patients with cardiac risk factors or electrolyte disturbances.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Letermovir and Ondansetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Letermovir with Ondansetron?

MediHelp rates the interaction as minor. Letermovir and Ondansetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Letermovir is a moderate CYP3A inhibitor and may modestly increase ondansetron levels. Since ondansetron has multiple clearance pathways, the effect is generally small.

How serious is the interaction between Letermovir and Ondansetron?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose adjustment is needed. Monitor for QT-related effects in patients with cardiac risk factors or electrolyte disturbances.

What other medicines interact with Ondansetron?

MediHelp also lists interactions of Ondansetron with, for example, Apomorphine, Thioridazine, Vandetanib. The full list is on the Ondansetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in